| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/26/2002 | WO2002074745A1 Method for producing cyclopentadiene compounds |
| 09/26/2002 | WO2002074726A2 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/26/2002 | WO2002032872A8 Nitrogenous aromatic ring compounds |
| 09/26/2002 | WO2002024636A3 N-acylsulfonamide apoptosis promoters |
| 09/26/2002 | WO1997019953A8 New lh-rh antagonists with improved effectiveness |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137939 Novel guanidinobenzamides |
| 09/26/2002 | US20020137936 Reacting anisidine with 3-chloropropionamide to form N-(4-methoxy phenyl)-3-chloropropionamide; intramolecular Friedel-Crafts cyclization with a Lewis acid; decomposition of salt; demethylation |
| 09/26/2002 | US20020137741 Use as topical antibiotics |
| 09/26/2002 | US20020137734 N-hydroxy-2-(2-(((4-((2-methyl-4-quinolinyl)methoxy)phenyl) -sulfonyl)methyl)-2-pyrrolidinyl)acetamide, for example and other quinoline containing N-hydroxyacetamide derivatives |
| 09/26/2002 | US20020137201 Detection of transmembrane potentials by optical methods |
| 09/26/2002 | CA2435847A1 Aniline derivatives useful as phosphodiesterase 4 inhibitors |
| 09/25/2002 | EP1243583A1 Heterocyclic compounds having sulfonamide groups |
| 09/25/2002 | EP1243582A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 09/25/2002 | EP1242427A1 Novel piperidine and piperazine derivatives |
| 09/25/2002 | EP1242402A2 Novel compounds |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242381A2 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof |
| 09/25/2002 | EP1242074A1 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | EP0835258B1 Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 09/24/2002 | US6455587 Aromatic sulfonyl derivatives |
| 09/24/2002 | US6455581 Inhibitors of hiv protease. |
| 09/24/2002 | US6455555 Photosensitizing dye that is a quinolinium- or thiazolium-methine dye |
| 09/24/2002 | US6455520 Benzamide derivatives and their use as cytokine inhibitors |
| 09/24/2002 | US6455502 Compounds and compositions as protease inhibitors |
| 09/24/2002 | US6455472 Herbicides, acaricides, nematicides and insecticides for crops |
| 09/24/2002 | CA2096223C Treatment for tissue ulceration |
| 09/19/2002 | WO2002072654A2 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 09/19/2002 | WO2002072578A2 (homo) piperazine substituted quinolines for inhibiting the phosphorylation of kinases |
| 09/19/2002 | WO2002072559A1 Process to intermediates for biologically active compounds |
| 09/19/2002 | WO2002072554A1 Anti-malarial compounds |
| 09/19/2002 | WO2002072532A1 7, 9-substituted tetracycline compounds |
| 09/19/2002 | WO2002071827A2 Retinoid x receptor modulators |
| 09/19/2002 | WO2002026730A3 Fluorinated quinolones as antimitotic and antitumor agents |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020132830 Use of beta 2 bronchodilator drugs |
| 09/19/2002 | US20020132826 Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 09/19/2002 | US20020132810 Novel heterocyclic amide derivatives |
| 09/19/2002 | US20020132806 Treatment of atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or Syndrome X |
| 09/19/2002 | US20020132796 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid. |
| 09/19/2002 | DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2441745A1 Polymers and oligomers, their synthesis, and electronic devices incorporating same |
| 09/19/2002 | CA2438586A1 Retinoid x receptor modulators |
| 09/18/2002 | WO2001072710A1 Heterocycle derivatives and drugs |
| 09/18/2002 | EP1240146A1 2-arylquinoline derivatives, preparation and therapeutic use thereof |
| 09/18/2002 | EP1239817A1 Use of methylchinolinium compounds for dyeing keratin containing fibers |
| 09/18/2002 | EP1039884B1 A method for the prevention and treatment of stunned myocardium |
| 09/18/2002 | EP0865424B1 Pesticides |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | EP0790237B1 Bicyclolactam compounds, use of the same and intermediate in the production of the same |
| 09/18/2002 | EP0700388B1 Substituted beta-aryl and beta-heteroaryl-alpha-cyanoacrylamide derivatives as tyrosine kinase inhibitors |
| 09/18/2002 | CN1370149A Method for preparing quinoline-5,8-diones |
| 09/18/2002 | CN1370148A Prepn. of quinoline-substituted carbonate and carbamate derivatives |
| 09/18/2002 | CN1370144A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 09/18/2002 | CN1370143A Propanoic acid derivatives that inhibit binding of integrins to their receptors |
| 09/18/2002 | CN1091103C Compounds of carbostyrils and their prepn. and use |
| 09/18/2002 | CN1091102C 7-chloro-4-oxo-quinoline and its prepn. method and novel use as medicine |
| 09/18/2002 | CA2403605A1 Heterocycle derivatives and drugs |
| 09/17/2002 | US6451792 Matrix metalloprotease inhibitors |
| 09/17/2002 | US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 09/17/2002 | CA2057338C Diarylfluoromethane compounds |
| 09/12/2002 | WO2002070541A2 Peptide deformylase inhibitors |
| 09/12/2002 | WO2002070509A2 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | WO2002070494A1 Aryl and heteroaryl urea chk1 inhibitors for use as radiosensitizers and chamosensitizers |
| 09/12/2002 | WO2002070492A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 09/12/2002 | WO2002070488A1 Process for producing quinoline-3-carboxylic acid compound |
| 09/12/2002 | WO2002070487A1 Substituted quinolinecarboxamides as antiviral agents |
| 09/12/2002 | WO2002070486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 09/12/2002 | WO2002069970A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/12/2002 | WO2002069901A2 Cathepsin cysteine protease inhibitors |
| 09/12/2002 | WO2001012600A9 INHIBITORS OF FACTOR Xa |
| 09/12/2002 | US20020128481 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/12/2002 | US20020128287 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 09/12/2002 | US20020128269 Piperazine derivatives |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | CA2440104A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 09/12/2002 | CA2439849A1 Antagonists of mcp-1 function and methods of use thereof |
| 09/12/2002 | CA2439827A1 Peptide deformylase inhibitors |
| 09/12/2002 | CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | CA2433467A1 Substituted quinolinecarboxamides as antiviral agents |
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1237953A2 Polymerization of olefins |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP1237546A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 09/11/2002 | EP0876349B1 Quinoline derivatives as gnrh antagonists |
| 09/11/2002 | EP0748799B1 Process for producing 5,7-dichloro-4-hydroxyquinoline |
| 09/11/2002 | CN1368961A Compounds for modulation of PPAP gamma activity |
| 09/11/2002 | CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives |
| 09/11/2002 | CN1368956A Carbamate derivatives and agricultural/horticultural bactericides |
| 09/11/2002 | CN1090612C Amine derivatives of oxo-and hydroxy-substituted hydrocarbons |
| 09/10/2002 | US6448405 Coupling a 2-halo-5-nitrobenzoic acid and a 2-methoxyphenyl boronic acid; cyclizing to a nitrobenzocoumarin; reducing to the amine; converting to a coumarino(3,4-f)quinoline; reduction to a 5h-chromeno(3,4-f)quinoline |
| 09/10/2002 | US6448399 3-cycloalkyl- or propyl-2-(3,4-dihalophenyl)-n-quinolinyl-, quinazolinyl-, or quinoxolinyl-propionamide. |
| 09/10/2002 | US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448259 Cycloalkyl-4-oxonicotinic carboxamides; agonists, antagonists or inverse agonists for gamma aminobutyric acid binding site, the benzodiazepine receptor; anxiety, sleep and seizure disorders sedative, anxiolytic and anticonvulsant activity |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |